Copyright
©The Author(s) 2020.
World J Hepatol. May 27, 2020; 12(5): 220-229
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.220
Published online May 27, 2020. doi: 10.4254/wjh.v12.i5.220
Figure 1 Comparison of Mac-2 binding protein glycosylation isomer levels against fibrosis staging by transient elastography in hepatitis C patients.
M2BPGi levels were plotted against fibrosis stages based on transient elastography. A: Mac-2 binding protein glycosylation isomer (M2BPGi) levels against fibrosis stages (F0-1, F2, and >F3); B: M2BPGi levels against fibrosis stages (F3 and F4); C: M2BPGi levels in treated and untreated cirrhosis patients. aP < 0.05. M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cut-off index; TE: Transient elastography.
Figure 2 Comparison of Mac-2 binding protein glycosylation isomer levels against other fibrosis markers in treatment naïve patients.
A: Mac-2 binding protein glycosylation isomer (M2BPGi) levels against transient elastography; B: M2BPGi levels against FIB-4; C: M2BPGi levels against aminotransferase to platelet ratio index. M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cut-off index; TE: Transient elastography; FIB-4: Fibrosis-4 index; APRI: Aspartate aminotransferase to platelet ratio index.
Figure 3 Comparison of Mac-2 binding protein glycosylation isomer levels against fibrosis staging by transient elastography in hepatitis B patients.
A: Mac-2 binding protein glycosylation isomer (M2BPGi) levels against fibrosis stages (F0-1, F2, and > F3); B: M2BPGi levels against fibrosis stages (F3 and F4). M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cut-off index; TE: Transient elastography.
Figure 4 Comparison of Mac-2 binding protein glycosylation isomer levels against hepatitis B viral load.
M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cut-off index; HBV: Hepatitis B virus.
Figure 5 Mac-2 binding protein glycosylation isomer levels in early liver disease (F0-1) due to different etiologies.
aP < 0.01. M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cut-off index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; NAFLD: Non-alcoholic fatty liver disease.
- Citation: Pham TTT, Ho DT, Nguyen T. Usefulness of Mac-2 binding protein glycosylation isomer in non-invasive probing liver disease in the Vietnamese population. World J Hepatol 2020; 12(5): 220-229
- URL: https://www.wjgnet.com/1948-5182/full/v12/i5/220.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i5.220